Evidence map›Paper›PMID 42893095›Full record

ArticleBioinformatics advances2026

It's a wrap: deriving distinct discoveries with FDR control after a GWAS analysis.

Benjamin B Chu, Zihuai He, Chiara Sabatti

Abstract read
In one paragraph

Article in Bioinformatics advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Benjamin B ChuDepartment of Biomedical Data Science, Stanford School of Medicine, Stanford, CA 94304, USA.ORCID https://orcid.org/0000-0001-8342-2361
Zihuai HeDepartment of Biomedical Data Science, Stanford School of Medicine, Stanford, CA 94304, USA.ORCID https://orcid.org/0000-0002-8220-4183
Chiara SabattiDepartment of Biomedical Data Science, Stanford School of Medicine, Stanford, CA 94304, USA.ORCID https://orcid.org/0000-0001-5829-9058

Funding

Stanford Alzheimer's Disease Research CenterAdmin Supp: Developing iPSC models for AD and PDP30AG066515 · NIA · STANFORD UNIVERSITY · PI Jennifer Kaci Fairchild · 2020 to 2026
$29.0M
A Latin American biobank for large-scale genetics research on severe mental illnessR01MH123157 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI FREIMER, NELSON B., LOPEZ JARAMILLO, CARLOS · 2020 to 2025
$10.6M
Genetics of Severe Mental IllnessR01MH113078 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BEARDEN, CARRIE E, FREIMER, NELSON B. · 2017 to 2021
$5.8M
Statistical and computational methods for integrative analysis of Alzheimer's Disease geneticsR01AG066206 · NIA · STANFORD UNIVERSITY · PI HE, ZIHUAI · 2019 to 2023
$3.5M
The pursuit of genetic causal mechanismsR56HG010812 · NHGRI · STANFORD UNIVERSITY · PI SABATTI, CHIARA · 2021 to 2022
$875k
NHGRI NIH HHS R56 HG010812NIA NIH HHS P30 AG066515NIA NIH HHS R01 AG066206NIMH NIH HHS R01 MH113078NIMH NIH HHS R01 MH123157
6 · The paper itself

Abstract

Motivation: The standard analysis pipeline for genome-wide association studies (GWAS) is based on marginal tests of association. These are computationally convenient and portable, but the discoveries are not immediately interpretable and require post-processing such as "clumping" and "fine mapping." An interesting alternative is provided by conditional independence hypotheses: their rejections lead to distinct signals across the genome, accounting for measured confounders and pointing to separate causal pathways. Recent work has shown how summary statistics resulting from the standard marginal GWAS can be used as input to test conditional independence hypotheses while controlling the false discovery rate (FDR). We previously developed a pipeline tailored to European genomes. Results: Here we introduce and release new software (solveblock) extending this capability to a much richer collection of studies. Given a set of genotyped samples, or a reference dataset, the new pipeline efficiently estimates the high-dimensional correlation matrices that describe dependencies across the genome, making rather common sparsity assumptions. Taking this sample-specific estimate as input, the software identifies groups of genetic variants that are highly correlated and uses them to define an appropriate resolution for conditional independence hypotheses. Finally, we compute the distribution for the exchangeable negative controls necessary to test these hypotheses. Simulations based on five UK Biobank sub-populations, illustrate the method's FDR control. The analysis of 26 phenotypes of varying polygenicity in British individuals, results in Availability and implementation: Our code, precompiled software, and processed files for these five sub-populations are openly shared.

Identifiers

PMID42893095
PMCPMC13676318

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.